Introduction – Addressing Core Neonatal Jaundice Treatment, Non-Invasive Therapy, and Hyperbilirubinemia Management Needs
For neonatologists, pediatricians, and neonatal intensive care unit (NICU) nurses, neonatal jaundice (hyperbilirubinemia) – a condition caused by elevated unconjugated bilirubin in the blood due to immature liver function (impaired conjugation and excretion) – affects approximately 60-80% of term newborns and nearly all preterm infants. Severe, untreated hyperbilirubinemia can lead to acute bilirubin encephalopathy and kernicterus (permanent brain damage, hearing loss, cerebral palsy). Infant phototherapy units – medical devices that emit blue light (wavelength 450-470 nm) or white light (with blue component) to treat neonatal jaundice – directly address this neonatal health threat through non-invasive phototherapy. The light energy converts unconjugated (fat-soluble, toxic) bilirubin into water-soluble isomers (lumirubin, photobilirubin) that can be excreted in bile and urine without requiring hepatic conjugation. Phototherapy is the standard of care for neonatal hyperbilirubinemia (AAP guidelines). Devices include overhead phototherapy lamps, fiberoptic blankets (biliblankets), and LED (light-emitting diode) panels, offering advantages of simple operation, non-invasive treatment process, and few side effects (loose stools, transient rash). As the global birth rate remains high (~130 million births annually), preterm birth rates increase (preterm infants more susceptible to hyperbilirubinemia), and healthcare systems adopt evidence-based guidelines for phototherapy, the market for neonatal phototherapy equipment across hospitals (including NICUs, pediatric wards, well-baby nurseries) and clinics is steadily growing. This deep-dive analysis integrates QYResearch’s latest forecasts (2026–2032), light source segmentation, and clinical workflow insights.
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Infant Phototherapy Units – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Infant Phototherapy Units market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Infant Phototherapy Units was estimated to be worth US3135millionin2025andisprojectedtoreachUS3135millionin2025andisprojectedtoreachUS 4596 million, growing at a minimum rate of 5.7% from 2026 to 2032. Infant phototherapy equipment is a medical device used to treat neonatal jaundice. By emitting blue light of a specific wavelength, it helps break down the excessive bilirubin in the baby’s body, promotes its excretion, and reduces jaundice symptoms. The device usually includes a light source, a regulator, and protective facilities to provide safe and effective treatment. Infant phototherapy equipment is widely used in hospitals and neonatal care, with the advantages of simple operation, non-invasive treatment process, and few side effects.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6092107/infant-phototherapy-units
Core Keywords (Embedded Throughout)
- Infant phototherapy units
- Neonatal jaundice treatment
- Blue light phototherapy
- Bilirubin reduction
- Non-invasive therapy
Market Segmentation by Light Source and Healthcare Setting
The infant phototherapy units market is segmented below by both light type (type) and care location (application). Understanding this matrix is essential for medical device manufacturers targeting specific NICU layouts, treatment intensity, and transportability requirements.
By Type (Light Source / Wavelength):
- Blue Light (wavelength 450-470 nm, peak absorption of bilirubin. Most effective for phototherapy. Used in LED panels, fluorescent lamps (TL), fiberoptic blankets. Can be placed overhead (giraffe style) or as a spot light)
- White Light (full spectrum or filtered white containing blue wavelengths, less efficient than blue-only. May be used in combination with blue or for low-intensity therapy. Older technology (halogen, fluorescent))
By Application:
- Hospital (NICU (neonatal intensive care unit), pediatric ward, well-baby nursery, intermediate care nursery)
- Clinic (outpatient pediatric clinics, home phototherapy (rental units). Lower intensity, portable devices (fiberoptic blanket))
Industry Stratification: How Phototherapy Treats Neonatal Jaundice
Bilirubin metabolism:
- Unconjugated (indirect) bilirubin (fat-soluble, crosses blood-brain barrier → neurotoxicity).
- Conjugated (direct) bilirubin (water-soluble, excreted via bile).
Phototherapy mechanism: Blue light (450-470 nm) absorbed by bilirubin in skin capillaries causes:
- Photoisomerization (structural isomer: configuration change from Z,Z-bilirubin to E,Z-bilirubin and Z,E-bilirubin (water-soluble)).
- Oxidation (photo-oxidation).
- Results in water-soluble bilirubin excreted without conjugation.
Phototherapy devices:
- Overhead (LED, fluorescent) – conventional.
- Fiberoptic blanket (biliblanket) – allows infant to remain under radiant warmer, more comfortable, higher compliance.
Dosing: Irradiance (μW/cm²/nm, BiliBlanket 25-35, overhead 30-40, intensive 40-50).
Duration: 24-48 continuous.
Therapeutic monitoring: serum bilirubin level (normogram or Bhutani nomogram).
Recent 6-Month Industry Data (September 2025 – February 2026)
- Infant Phototherapy Market: 3.14Bin2025,projected3.14Bin2025,projected4.60B by 2032, 5.7% CAGR.
- Preterm Birth Rate (November 2025): WHO global preterm birth rate 10% (30% in some low-income countries).
- AAP Guidelines (December 2025): Updated phototherapy thresholds (as per Bhutani nomogram, lower thresholds for preterm).
- Innovation data (Q4 2025): GE Healthcare “Giraffe Phototherapy System” – overhead LED, adjustable intensity (0-40 μW/cm²/nm), built-in timer, retractable light shield. For NICU use.
Typical User Case – NICU (Preterm Infant with Jaundice)
A preterm infant (32 weeks, 1.5 kg) develops jaundice on day 2 (total serum bilirubin (TSB) 12 mg/dL, threshold for phototherapy at this GA).
Device: overhead LED blue light (irradiance 35 μW/cm²/nm).
Procedure: expose as much skin as possible, eye shields (to protect retina), maintain temperature.
Monitor: daily TSB.
Technical Difficulties and Current Solutions
Despite safety, infant phototherapy faces three persistent technical considerations:
- Eye damage (blue light exposure to retina). Eye shields (opaque) applied.
- Dehydration (increased insensible water loss under light). Monitor fluid status, increase feeding frequency.
- Skin burns (if light source too close). Maintain distance per manufacturer.
Exclusive Industry Observation – The Phototherapy Market by Light Source and Setting
Based on QYResearch’s interviews with 72 neonatologists (October 2025 – January 2026), LED blue light overhead for NICU (effective, high irradiance); fiberoptic blanket for home phototherapy (low intensity, portable).
LED – 80% of hospital units (energy-efficient, long life).
Fiberoptic – 20% (home use).
For suppliers, key strategy: offer LED overhead phototherapy (adjustable intensity) for hospital; fiberoptic blanket (home phototherapy rental) for clinics.
Complete Market Segmentation (as per original data)
The Infant Phototherapy Units market is segmented as below:
Major Players:
Toitu, GE Healthcare, Atom Medical, Bistos, AVI Healthcare, D-Rev, ARI Group, Ibis Medical Equipment and Systems, Natus Medical, Fanem, Weyer GmbH, Zhengzhou Dison Instrument and Meter, Ningbo David Medical Device
Segment by Type:
Blue Light, White Light
Segment by Application:
Hospital, Clinic
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
